A Look At BioMarin (BMRN) Valuation After Recent Share Price Rebound [Yahoo! Finance]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: Yahoo! Finance
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. BioMarin Pharmaceutical (BMRN) has been drawing attention after recent share price moves, with the stock up about 9% over the past month and roughly 12% over the past 3 months. See our latest analysis for BioMarin Pharmaceutical. That recent 9% 30 day share price return and 12% 90 day share price return sit against a weaker backdrop, with the 1 year total shareholder return around 13% lower. This suggests that short term momentum has picked up even as longer term holders remain under pressure. If BioMarin's recent rebound has you thinking about where else growth stories may emerge in healthcare, it could be worth scanning our list of 27 healthcare AI stocks as a starting point for ideas. With BioMarin reporting revenue of US$3.2b and net income of US$348.9m, yet trading about 43% below the average analyst price target, the key questio
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- BioMarin Pharmaceutical Inc. (BMRN) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]Seeking Alpha
- BioMarin Pharmaceutical (BMRN) had its "overweight" rating reaffirmed by Barclays PLC.MarketBeat
- BioMarin Pharmaceutical (BMRN) was given a new $105.00 price target by Loop Capital.MarketBeat
- Spruce Biosciences Touts MPS IIIB Data, Targets Q4 BLA Submission at Oppenheimer Conference [Yahoo! Finance]Yahoo! Finance
- Canaccord Lifts PT on BioMarin Pharmaceutical (BMRN) to $104 From $98 – Here's Why [Yahoo! Finance]Yahoo! Finance
BMRN
Earnings
- 2/23/26 - Beat
BMRN
Sec Filings
- 2/26/26 - Form 4
- 2/26/26 - Form 4
- 2/26/26 - Form 4
- BMRN's page on the SEC website